Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Application of Direct Viral Cytopathic Hypothesis to Design Drug Trials in the Battle Against Covid-19 Publisher Pubmed



Ashraf MA1 ; Sherafat A2 ; Pourdast A3, 4 ; Nazemi P4 ; Mohraz M3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Shiraz University of Medical Sciences, Shiraz, Iran
  2. 2. School of Medicine, University of Central Lancashire, Preston, United Kingdom
  3. 3. Iranian Research Center for HIV/AIDS (IRCHA), District 6, Imam Khomeini Hospital, Keshavarz Blvd, Nosrat St, Tehran, Tehran Province, Iran
  4. 4. Tehran University of Medical Sciences, Tehran, Iran

Source: DARU# Journal of Pharmaceutical Sciences Published:2020


Abstract

COVID-19 has caused many deaths worldwide. Systemic complications alongside coagulopathy, and ARDS account for the majority of COVID-19 mortalities. The pathogenesis of the disease can be explained by two theories of direct viral cytopathy and systemic inflammatory cascade of events. ACE-2 is shown to be the cellular host receptor for SARS-CoV-2. It might be the key to explain the pathogenesis of systemic complications with a focus on the direct viral cytopathic hypothesis. Different medications tend to show up in many in vitro drug screens. However, more trials are needed to translate their application into in vivo efficacy. © 2020, Springer Nature Switzerland AG.
Other Related Docs
16. The Immunologic Basis of Covid-19: A Clinical Approach, Journal of Cellular and Molecular Anesthesia (2020)
19. Immune-Based Therapy for Covid-19, Advances in Experimental Medicine and Biology (2021)
20. The Prophylaxis and Treatment Potential of Supplements for Covid-19, European Journal of Pharmacology (2020)
22. Pharmacological Treatments of Covid-19, Pharmacological Reports (2020)
23. Advances in Immunotherapy for Covid-19: A Comprehensive Review, International Immunopharmacology (2021)
27. Fatty Liver in Covid-19: A Risk Factor or a Common Receptor?, Archives of Iranian Medicine (2021)
29. Covid-19 Infection and Stroke Risk, Reviews in the Neurosciences (2021)
36. Soluble Ace2 As a Risk or Prognostic Factor in Covid-19 Patients: A Cross-Sectional Study, Medical Journal of the Islamic Republic of Iran (2022)
37. Immune Profiling of Sars-Cov-2; What We Know and What We Don’T Know, Iranian Journal of Allergy# Asthma and Immunology (2023)
41. Cytokines and Covid-19: Friends or Foes?, Human Vaccines and Immunotherapeutics (2020)
42. Variable Clinical Manifestations of Covid-19: Viral and Human Genomes Talk, Iranian Journal of Allergy# Asthma and Immunology (2020)
44. Pathologic Features of Covid-19: A Concise Review, Pathology Research and Practice (2020)
50. Introduction on Coronavirus Disease (Covid-19) Pandemic: The Global Challenge, Advances in Experimental Medicine and Biology (2021)